Top Markets
Coin of the day
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
อันดับในหุ้น #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
ราคาหุ้น
$63.48
ซิงค์ล่าสุด: 2024-12-17
มูลค่าตลาด
$11.52B
การเปลี่ยนแปลง (1 วัน)
0.00%
การเปลี่ยนแปลง (1 ปี)
0.00%
ประเทศ
US
ซื้อขาย Catalent, Inc. (CTLT)

หมวดหมู่

EPS สำหรับ Catalent, Inc. (CTLT)
EPS ณ วันที่ September 2024 TTM: $-2.26
จากรายงานทางการเงินล่าสุดและราคาหุ้นของ Catalent, Inc. EPS ปัจจุบันของบริษัท (TTM) คือ $-2.26 สิ้นปี 2023 บริษัทมี EPS เท่ากับ $-1.28 น้อยกว่ารายได้ในปี EPS ในปี 2022 ซึ่งอยู่ที่ $2.74
ประวัติ EPS ของ Catalent, Inc. ตั้งแต่ 2011 ถึง 2026
EPS ณ สิ้นแต่ละปี
ปี EPS เปลี่ยน
2026 (TTM) $-2.26 -60.76%
2024 $-5.76 350.00%
2023 $-1.28 -146.72%
2022 $2.74 -13.02%
2021 $3.15 173.91%
2020 $1.15 21.05%
2019 $0.95 48.44%
2018 $0.64 -27.27%
2017 $0.88 -1.12%
2016 $0.89 -49.72%
2015 $1.77 1,164.29%
2014 $0.14 -135.00%
2013 $-0.40 90.48%
2012 $-0.21 -54.35%
2011 $-0.46 0.00%
EPS สำหรับบริษัทหรือคู่แข่งที่คล้ายกัน
บริษัท EPS ความแตกต่างของ EPS ประเทศ
- -
DE
- -
DE
- -
JP
- -
CH
$0.56 -124.62%
IN